FDA NDC Directory · JSON-LD · Markdown

INLEXZO

NDC 57894-225 · HUMAN PRESCRIPTION DRUG · SYSTEM

Generic namegemcitabine intravesical
Labeler / ManufacturerJanssen Biotech, Inc
Marketing categoryNew Drug Application (innovator) · App NDA219683
Dosage form / routeSYSTEM · INTRAVESICAL
Active ingredientsGEMCITABINE (225 mg/1)
Marketing started20250914
Package count2

External sources

Source: openFDA. Public-domain (CC0).